Gene: LEPROTL1
Official Full Name: leptin receptor overlapping transcript like 1provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in late endosome to vacuole transport via multivesicular body sorting pathway and negative regulation of growth hormone receptor signaling pathway. Predicted to be located in membrane. Predicted to be active in endosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29260 | LEPROTL1 Knockout cell line (HeLa) | Human | LEPROTL1 | 1:3~1:6 | Negative | Online Inquiry |
KO29261 | LEPROTL1 Knockout cell line (HCT 116) | Human | LEPROTL1 | 1:2~1:4 | Negative | Online Inquiry |
KO29262 | LEPROTL1 Knockout cell line (HEK293) | Human | LEPROTL1 | 1:3~1:6 | Negative | Online Inquiry |
KO29263 | LEPROTL1 Knockout cell line (A549) | Human | LEPROTL1 | 1:3~1:4 | Negative | Online Inquiry |
LEPROTL1 Gene Knockout Cell Lines are specially developed cell lines engineered to disrupt the expression of the LEPROTL1 gene, which is implicated in various physiological and pathological processes, including immune response and cellular development. These knockout cell lines serve as invaluable tools for researchers exploring the functional roles and molecular mechanisms of the LEPROTL1 gene in various biological contexts.
The primary function of LEPROTL1 Gene Knockout Cell Lines lies in their ability to provide insights into the cellular pathways and interactions mediated by the LEPROTL1 protein. By utilizing CRISPR/Cas9 or other gene-editing technologies, these cell lines facilitate the in-depth study of gene function and regulatory networks. Researchers can observe alterations in cell behavior, including changes in proliferation, apoptosis, and differentiation, enabling a better understanding of how LEPROTL1 affects overall cellular homeostasis.
The scientific significance of these cell lines extends to their application in both research and clinical settings. They assist in elucidating the gene’s role in various diseases, including autoimmune disorders and cancer, thus paving the way for developing targeted therapies and interventions. Moreover, these knockout models can serve as platforms for drug screening or pharmacological studies, offering a more precise substrate compared to traditional models.
One of the compelling advantages of LEPROTL1 Gene Knockout Cell Lines is their specificity and reliability in gene functional studies, surpassing alternative methods that may introduce unreliable variables or incomplete knockout efficiencies. This results in reproducible data, enhancing the credibility of experimental outcomes.
For researchers, clinicians, and biopharmaceutical developers, these knockout cell lines represent a powerful asset in the quest for medical advancements. By unlocking new avenues for investigation into gene function and disease etiology, they contribute significantly to the acceleration of scientific innovation.
With our expertise in genetic engineering and a commitment to quality, our company provides LEPROTL1 Gene Knockout Cell Lines that meet the highest standards for accuracy and reliability, empowering researchers to make groundbreaking discoveries in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.